Josep Rodés-Cabau, MD, PhD

Original Contribution

ECG-Guided Immediate Intervention at the Time of Primary PCI

11/04/2008

Gérald Barbeau , MD;

Onil Gleeton , MD;

Olivier F. Bertrand , MD, PhD;

Louis Roy , MD;

Robert De Larochellière , MD;

Jonathan Beaudoin , MD;

Josep Rodés-Cabau , MD, PhD;

Can Manh Nguyen , MD;

Philippe Lachance ;

Bernard Noel , MD;

Eric Larose , MD, DVM;

Jean-Pierre Dery , MD, MSc;

Guy Proulx , MD;

To Reduce Door-to-Balloon Time in ST-Elevation Myocardial Infarction Patients ABSTRACT: Background. In ST-segment elevation acute myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI), all efforts...

To Reduce Door-to-Balloon Time...

11/04/2008

Journal of Invasive Cardiology

Plaque Sealing With Drug-Eluting Stents Versus Medical Therapy for Treating Intermediate Non-Obstructive Saphenous Vein Graft Lesions: A Pooled Analysis of the VELETI and VELETI II Trials

10/29/2019

Sanjit S. Jolly , MD, MSc, FRCP;

Vladimír Dzavík , MD, FRCPC, FSCAI;

Josep Rodés-Cabau , MD, PhD;

Frédéric Maes , MD, PhD;

John Cairns , MD;

Robert De Larochellière , MD;

Melanie Côté , MD, MSc;

The presence of intermediate “non-obstructive” saphenous vein graft lesions is a strong predictor of cardiac events. Our study aims to assess the efficacy of sealing these saphenous vein graft lesions with drug-eluting stent implantation for...

The presence of intermediate...

10/29/2019

Journal of Invasive Cardiology

Clinical Trial Update: Small Aortic Annulus

The VIVA Trial: TAVR Versus SAVR in Patients With Severe Aortic Stenosis and Small Aortic Annuli

10/31/2023

Josep Rodés-Cabau , MD, PhD;

"TAVR and SAVR represent a valid alternative for treating patients with aortic stenosis and small aortic annulus,” concluded Dr. Rodés-Cabau.

"TAVR and SAVR represent a valid...

10/31/2023

Cath Lab Digest

Author Interview

Sensor-Guided Transcatheter Aortic Valve Replacement: An Interview With Josep Rodés-Cabau, MD, PhD

02/15/2024

Josep Rodés-Cabau , MD, PhD;

Dr Josep Rodés-Cabau shares background and insights on his paper, "Sensor-Guided Transcatheter Aortic Valve Replacement."

Dr Josep Rodés-Cabau shares...

02/15/2024

Journal of Invasive Cardiology

Original Contribution

Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement in the Era of New-Generation Devices

03/25/2022

Teresa Romero Delgado , MD;

Gabriela Tirado-Conte , MD;

Pilar Jimenez-Quevedo , MD;

Angela McInerney , MD;

Luis Marroquin , MD;

Alberto Alperi , MD, PhD;

Laurent Faroux , MD, MSc;

Guillem Muntane-Carol , MD;

Siamak Mohammadi , MD;

Eric Dumont , MD;

Robert De La Rochelliere , MD;

Josep Rodés-Cabau , MD, PhD;

Dimitri Kalavrouziotis , MD;

Jean-Michel Paradis , MD;

Luis Nombela-Franco , MD;

Carlos Macaya , MD, PhD;

Maxime Tetu-Couture , MS;

Unplanned hospital readmissions after transcatheter aortic valve replacement (TAVR) are frequent and have been associated with a poor prognosis. The authors sought to determine the trends in the incidence and causes of unplanned hospital...

Unplanned hospital readmissions...

03/25/2022

Journal of Invasive Cardiology

Clinical Impact of Crossover Techniques for Primary Access Hemostasis in Transfemoral Transcatheter Aortic Valve Replacement Procedures

04/01/2021

Jean-Michel Paradis , MD;

Alberto Alperi , MD, PhD;

Manel Sabaté , MD, PhD;

Thomas Couture , MS;

Marina Urena , MD;

Antonio Munoz-Garcia , MD;

Vicenç Serra ;

Dominique Himbert , MD;

Erika Munoz-Garcia , MD;

Isaac Pascual , MD;

Bruno Garcia Del Blanco , MD;

Antonio Colombo , MD;

Melanie Côté , MD, MSc;

Ander Regueiro , MD;

Azeem Latib , MD, BCh, MBBCh;

Lucia Junquera , MD;

Quentin Fisher , MD;

Benjamin Faurie , MD, PhD;

Guillem Muntane-Carol , MD;

Rafael Vera Urquiza , MD;

Antonio Mangieri , MD;

Siamak Mohammadi , MD;

Afonso B. Freitas-Ferraz , MD;

Luis Nombela-Franco , MD;

Josep Rodés-Cabau , MD, PhD;

Pilar Jimenez-Quevedo , MD;

Our objective was to determine the occurrence of vascular complications following transfemoral transcatheter aortic valve replacement with new-generation devices according to the use of a crossover technique.

Our objective was to determine...

04/01/2021

Journal of Invasive Cardiology

Original Contribution

Secondary Femoral Access Hemostasis During Transcatheter Aortic Valve Replacement: Impact of Vascular Closure Devices

08/01/2021

Marina Urena , MD;

Antonio Munoz-Garcia , MD;

Gabriela Veiga-Fernandez , MD;

Vicenç Serra ;

Quentin Fischer , MD;

Dominique Himbert , MD;

Erika Munoz-Garcia , MD;

Rafael Vera-Urquiza , MD;

Laurent Faroux , MD, MSc;

Isaac Pascual , MD;

Lucia Junquera , MD;

Bruno Garcia Del Blanco , MD;

Josep Rodés-Cabau , MD, PhD;

Siamak Mohammadi , MD;

Melanie Côté , MD, MSc;

Benjamin Faurie , MD, PhD;

Luis Nombela-Franco , MD;

Pilar Jimenez-Quevedo , MD;

Alberto Alperi , MD, PhD;

Thomas Couture , MS;

Jose de la Torre Hernandez , MD, PhD;

Vascular and bleeding complications related to secondary femoral access site are frequent in patients undergoing TAVR, and their occurrence is associated to poorer outcomes. We aimed to evaluate the clinical impact of VCDs for secondary...

Vascular and bleeding...

08/01/2021

Journal of Invasive Cardiology

Percutaneous Transcatheter Valve-in-Valve Implantation With the Balloon-Expandable Valve for the Treatment of a Dysfunctional Tricuspid Bioprosthetic Valve ‚Äî A Pediatric Case Report

06/04/2013

Nagib Dahdah , MD;

Josep Rodés-Cabau , MD, PhD;

Baher Matta Hanna , MD;

An inverted Edwards SAPIEN 23mm valve was implanted in a 14 year-old patient with Ebstein's anomaly and immediate drop of right atrial and trans-tricuspid pressures with mild regurgitation, and stable results on short-term follow-up.

An inverted Edwards SAPIEN 23mm...

06/04/2013

Journal of Invasive Cardiology

Original Contribution

Clinical Outcomes after Multilesion Percutaneous Coronary
Intervention: Comparison between Exclusive and Selective
Use of Drug

08/01/2008

Robert De Larochellière , MD;

Olivier F. Bertrand , MD, PhD;

Benjamin Faurie , MD, PhD;

Bernard Noel , MD;

Josep Rodés-Cabau , MD, PhD;

Guy Proulx , MD;

Eric Larose , MD, DVM;

Can Manh Nguyen , MD;

Onil Gleeton , MD;

Jean-Pierre Dery , MD, MSc;

Louis Roy , MD;

Olivier Costerousse , PhD;

Drug-eluting stents (DES) have revolutionized modern interventional cardiology by providing distinct advantages over bare-metal stents (BMS) in reducing the risk of in-stent restenosis. Several randomized clinical trials have consistently...

Drug-eluting stents (DES) have...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Clinical Outcomes after Multilesion Percutaneous Coronary
Intervention: Comparison between Exclusive and Selective
Use of Drug

08/01/2008

Can Manh Nguyen , MD;

Bernard Noel , MD;

Guy Proulx , MD;

Olivier F. Bertrand , MD, PhD;

Eric Larose , MD, DVM;

Onil Gleeton , MD;